Lixivaptan for hyponatremia--the numbers game - PubMed (original) (raw)
. 2012 Dec 12;308(22):2345-6.
doi: 10.1001/jama.2012.54515.
Affiliations
- PMID: 23232892
- DOI: 10.1001/jama.2012.54515
Lixivaptan for hyponatremia--the numbers game
Ryan T Borne et al. JAMA. 2012.
No abstract available
Similar articles
- Treatment of hyponatremia: the role of lixivaptan.
Liamis G, Filippatos TD, Elisaf MS. Liamis G, et al. Expert Rev Clin Pharmacol. 2014 Jul;7(4):431-41. doi: 10.1586/17512433.2014.911085. Epub 2014 Apr 28. Expert Rev Clin Pharmacol. 2014. PMID: 24766294 Review. - Lixivaptan, a non-peptide vasopressin V2 receptor antagonist for the potential oral treatment of hyponatremia.
Ghali JK, Zmily HD, Farah JO, Daifallah S. Ghali JK, et al. IDrugs. 2010 Nov;13(11):782-92. IDrugs. 2010. PMID: 21046526 Review. - AVP receptor antagonists in patients with CHF.
Kumar SK, Mather PJ. Kumar SK, et al. Heart Fail Rev. 2009 Jun;14(2):83-6. doi: 10.1007/s10741-008-9107-9. Epub 2008 Sep 3. Heart Fail Rev. 2009. PMID: 18766439 Review. - Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia.
Abraham WT, Decaux G, Josiassen RC, Yagil Y, Kopyt N, Thacker HP, Mannelli M, Bichet DG, Orlandi C; HARMONY Study Group. Abraham WT, et al. Kidney Int. 2012 Dec;82(11):1215-22. doi: 10.1038/ki.2012.274. Epub 2012 Aug 29. Kidney Int. 2012. PMID: 22932122 Clinical Trial. - Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia.
Abraham WT, Hensen J, Gross PA, Bichet DG, Josiassen RC, Chafekar DS, Orlandi C; LIBRA Study Group. Abraham WT, et al. Kidney Int. 2012 Dec;82(11):1223-30. doi: 10.1038/ki.2012.275. Epub 2012 Aug 29. Kidney Int. 2012. PMID: 22932119 Clinical Trial.
Cited by
- Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines.
Hoorn EJ, Zietse R. Hoorn EJ, et al. J Am Soc Nephrol. 2017 May;28(5):1340-1349. doi: 10.1681/ASN.2016101139. Epub 2017 Feb 7. J Am Soc Nephrol. 2017. PMID: 28174217 Free PMC article. Review. - Lixivaptan - an evidence-based review of its clinical potential in the treatment of hyponatremia.
Bowman BT, Rosner MH. Bowman BT, et al. Core Evid. 2013;8:47-56. doi: 10.2147/CE.S36744. Epub 2013 Jul 11. Core Evid. 2013. PMID: 23874242 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical